Co-expression by keratinocytes of migration stimulating factor (MSF) and a functional inhibitor of its bioactivity (MSFI)

Experimental Cell Research

Volumn 313, Issue 20, 2007, Pages 4145-4157

  Jones, Sarah J ^a   Florence, Margaret M ^a   Ellis, Ian R ^a   Kankova, Katerina ^a,b   Schor, Seth L ^a   Schor, Ana M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Cancer progression; Fibroblasts; HaCaT; Keratinocytes; Lipocalin; Migration inhibitor; MSF; NGAL; Wound healing

Indexed keywords

LIPOCALIN; MIGRATION STIMULATING FACTOR; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WOUND HEALING;

EID: 36048999152     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2007.09.009     Document Type: Article

References (48)

1. Schor S.L., Ellis I.R., Jones S.J., Baillie R., Seneviratne K., Clausen J., Motegi K., Vojtesek B., Kankova K., Furrie E., Sales M.J., Schor A.M., and Kay R.A. Migration-stimulating factor: a genetically truncated onco-fetal fibronectin isoform expressed by carcinoma and tumor-associated stromal cells. Cancer Res. 63 (2003) 8827-8836
2. Schor S.L., and Schor A.M. Tumour-stroma interactions. Phenotypic and genetic alterations in mammary stroma: implications for tumour progression. Breast Cancer Res. 3 (2001) 373-379
3. Schor S.L., Schor A.M., Keatch R.P., and Belch J.J.F. Role of matrix macromolecules in the aetiology and treatment of chronic ulcers. In: Lee B.Y. (Ed). The Wound Management Manual (2005), McGraw Hill, New York 109-121 Chapter 10
4. Houard X., Germain S., Gervais M., Michaud A., van den Brule F., Foidart J.-M., Noel A., Monnot C., and Corvol P. Migration-stimulating factor displays HEXXH-dependent catalytic activity important for promoting tumor cell migration. Int. J. Cancer 116 (2005) 378-384
5. Schor S.L., Schor A.M., Rushton G., and Smith L. Adult, foetal and transformed fibroblasts display different migratory phenotypes on collagen gels-evidence for an isoformic transition during foetal development. J. Cell Sci. 73 (1985) 221-234
6. Schor S.L., Schor A.M., Grey A.M., and Rushton G. Foetal and cancer patient fibroblasts produce an autocrine migration-stimulating factor not made by normal adult cells. J. Cell Sci. 90 (1988) 391-399
7. Grey A.-M., Schor A.M., Rushton G., Ellis I., and Schor S.L. Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 2438-2442
8. Schor S.L., Schor A.M., Grey A.M., Chen J., Rushton G., Grant M.E., and Ellis I. Mechanism of action of the migration stimulating factor produced by fetal and cancer patient fibroblasts: effect on hyaluronic acid synthesis. In Vitro Cell. Dev. Biol. 25 (1989) 737-746
9. Schor S.L. Cell proliferation and migration on collagen substrata in vitro. J. Cell Sci. 41 (1980) 159-175
10. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., and Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106 (1988) 761-771
11. Watt F.M., and Green H. Involucrin synthesis is correlated with cell size in human epidermal cultures. J. Cell Biol. 90 (1981) 738-742
12. Rheinwald J.G., and Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6 (1975) 331-344
13. Schor A.M., Rushton G., Ferguson J.E., Howell A., Redford J., and Schor S.L. Phenotypic heterogeneity in breast fibroblasts-functional anomaly in fibroblasts from histologically normal tissue adjacent to carcinoma. Int. J. Cancer 59 (1994) 25-32
14. Schor S.L., Ellis I., Banyard J., and Schor A.M. Motogenic activity of IGD-containing synthetic peptides. J. Cell Sci. 112 (1999) 3879-3888
15. Schor S.L., Ellis I.R., Harada K., Motegi K., Anderson A.R.A., Chaplain M.A.J., Keatch R.P., and Schor A.M. A novel 'sandwich' assay for quantifying chemo-regulated cell migration within 3-dimensional matrices: wound healing cytokines exhibit distinct motogenic activities compared to the transmembrane assay. Cell Motil. Cytoskelet. 63 (2006) 287-300
16. Laemmli U.K. Cleavage of structural proteins during assembly of head of bacteriophage-T4. Nature 227 (1970) 680-685
17. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 4350-4354
18. Ellis I., Grey A.M., Schor A.M., and Schor S.L. Antagonistic effects of TGF-β1 and MSF on fibroblast migration and hyaluronic acid synthesis-possible implications for dermal wound healing. J. Cell Sci. 102 (1992) 447-456
19. Hvidberg V., Jacobsen C., Strong R.K., Cowland J.B., Moestrup S.K., and Borregaard N. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett. 579 (2005) 773-777
20. Devireddy L.R., Gazin C., Zhu X.C., and Green M.R. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 123 (2005) 1293-1305
21. Hanai J., Mammoto T., Seth P., Mori K., Karumanchi S.A., Barasch J., and Sukhatme V.P. Lipocalin 2 diminishes invasiveness and metastasis of Ras-transformed cells. J. Biol. Chem. 280 (2005) 13641-13647
22. Kjeldsen L., Johnsen A.H., Sengelov H., and Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem. 268 (1993) 10425-10432
23. 2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase. FEBS Lett. 314 (1992) 386-388
24. Xu S.Y., Carlson M., Engstrom Å., Garcia R., Peterson C.G.B., and Venge P. Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils. Scand. J. Clin. Lab. Invest. 54 (1994) 365-376
25. Goetz D.H., Holmes M.A., Borregaard N., Bluhm M.E., Raymond K.N., and Strong R.K. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell 10 (2002) 1033-1043
26. Flo T.H., Smith K.D., Sato S., Rodriguez D.J., Holmes M.A., Strong R.K., Akira S., and Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432 (2004) 917-921
27. Yang J., Goetz D., Li J.Y., Wang W.G., Mori K., Setlik D., Du T.G., Erdjument-Bromage H., Tempst P., Strong R., and Barasch J. An iron delivery pathway mediated by a lipocalin. Mol. Cell 10 (2002) 1045-1056
28. Schmidt-Ott K.M., Mori K., Kalandadze A., Li J.Y., Paragas N., Nicholas T., Devarajan P., and Barasch J. Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr. Opin. Nephrol. Hypertens. 15 (2006) 442-449
29. Playford R.J., Belo A., Poulsom R., Fitzgerald A.J., Harris K., Pawluczyk I., Ryon J., Darby T., Nilsen-Hamilton M., Ghosh S., and Marchbank T. Effects of mouse and human lipocalin homologues 24p3/lcn2 and neutrophil gelatinase-associated lipocalin on gastrointestinal mucosal integrity and repair. Gastroenterology 131 (2006) 809-817
30. Gwira J.A., Wei F., Ishibe S., Ueland J.M., Barasch J., and Cantley L.G. Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro. J. Biol. Chem. 280 (2005) 7875-7882
31. Yan L., Borregaard N., Kjeldsen L., and Moses M.A. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL)-modulation of MMP-9 activity by NGAL. J. Biol. Chem. 276 (2001) 37258-37265
32. Tschesche H., Zölzer V., Triebel S., and Bartsch S. The human neutrophil lipocalin supports the allosteric activation of matrix metalloproteinases. Eur. J. Biochem. 268 (2001) 1918-1928
33. Kolkenbrock H., HeckerKia A., Orgel D., Kinawi A., and Ulbrich N. Progelatinase B forms from human neutrophils. Complex formation of monomer/lipocalin with TIMP-1. Biol. Chem. 377 (1996) 529-533
34. Coles M., Diercks T., Muehlenweg B., Bartsch S., Zolzer V., Tschesche H., and Kessler H. The solution structure and dynamics of human neutrophil gelatinase-associated lipocalin. J. Mol. Biol. 289 (1999) 139-157
35. Goetz D.H., Willie S.T., Armen R.S., Bratt T., Borregaard N., and Strong R.K. Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin. Biochemistry 39 (2000) 1935-1941
36. Van den Steen P.E., Opdenakker G., Wormald M.R., Dwek R.A., and Rudd P.M. Matrix remodelling enzymes, the protease cascade and glycosylation. Biochim. Biophys. Acta, Gen. Subj. 1528 (2001) 61-73
37. Schor S.L. Cytokine control of cell motility: modulation and mediation by the extracellular matrix. Prog. Growth Factor Res. 5 (1994) 223-248
38. Ellis I.R., Banyard J., and Schor S.L. Motogenic and biosynthetic response of adult skin fibroblasts to TGF-β isoforms (-1, -2, and -3) determined by "tissue response unit": role of cell density and substratum. Cell Biol. Int. 23 (1999) 593-602
39. Schor S.L., Ellis I., Dolman C., Banyard J., Humphries M.J., Mosher D.F., Grey A.M., Mould A.P., Sottile J., and Schor A.M. Substratum-dependent stimulation of fibroblast migration by the gelatin-binding domain of fibronectin. J. Cell Sci. 109 (1996) 2581-2590
40. Ellis I.R., Schor A.M., and Schor S.L. EGF and TGF-α motogenic activities are mediated by the EGF receptor via distinct matrix-dependent mechanisms. Exp. Cell Res. 313 (2007) 732-741
41. Coles M., Diercks T., Muehlenweg B., Bartsch S., Zölzer V., Tschesche H., and Kessler H. The solution structure and dynamics of human neutrophil gelatinase-associated lipocalin. J. Mol. Biol. 289 (1999) 139-157
42. Li E.-M., Xu L.-Y., Cai W.-J., Xiong H.-Q., Shen Z.-Y., and Zeng Y. Functions of neutrophil gelatinase-associated lipocalin in the esophageal carcinoma cell line SHEEC. Acta Biochim. Biophys. Sin. 35 (2003) 247-254
43. Bratt T. Lipocalins and cancer. Biochim. Biophys. Acta 1482 (2000) 318-326
44. Fernandez C.A., Yan L., Louis G., Yang J., Kutok J.L., and Moses M.A. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin. Cancer Res. 11 (2005) 5390-5395
45. Lee H.-J., Lee E.-K., Lee K.-J., Hong S.-W., Yoon Y., and Kim J.S. Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells. Int. J. Cancer 118 (2006) 2490-2497
46. Bussolino F., DiRenzo M.F., Ziche M., Bocchietto E., Olivero M., Naldini L., Gaudino G., Tamagnone L., Coffer A., and Comoglio M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 119 (1992) 629-641
47. Stoker M., Gherardi E., Perryman M., and Gray J. Scatter factor is a fibroblast-derived modulator of epithelial-cell mobility. Nature 327 (1987) 239-242
48. Gherardi E., Gray J., Stoker M., Perryman M., and Furlong R. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 5844-5848